iodixanol has been researched along with Acute Kidney Failure in 92 studies
iodixanol: dimeric contrast media; structure given in first source
iodixanol : A dimeric, non-ionic, water-soluble, radiographic contrast agent, used particularly in coronary angiography.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate iodixanol-associated acute kidney injury (AKI) and prognosis in patients undergoing elective percutaneous coronary intervention (PCI)." | 8.31 | Iodixanol-associated acute kidney injury and prognosis in patients undergoing elective percutaneous coronary intervention: a prospective, multi-center study. ( Azzalini, L; Chen, Z; Huang, L; Jiang, Y; Mao, Q; Xiang, L; Zhao, N; Zhao, X; Zhou, D, 2023) |
| "To determine the incidence of post-contrast acute kidney injury (PC-AKI) and presumed contrast-induced acute kidney injury (CI-AKI) following contrast-enhanced CT (CECT) with intravenous application of a reduced dose of the iso-osmolar contrast agent iodixanol in cancer patients with chronic kidney disease." | 7.96 | Incidence of contrast-induced acute kidney injury (CI-AKI) in high-risk oncology patients undergoing contrast-enhanced CT with a reduced dose of the iso-osmolar iodinated contrast medium iodixanol. ( Bez, C; Hinterleitner, C; Horger, M; Werner, S, 2020) |
| "In this study, we tested the hypothesis that fasudil, a Rho kinase inhibitor, would protect against contrast-induced acute kidney injury (CI-AKI) in a mouse model and attempted to elucidate the mechanism involved." | 7.88 | Rho Kinase Inhibitor, Fasudil, Attenuates Contrast-induced Acute Kidney Injury. ( Miao, D; Wang, Y; Yang, Z; Zhang, D; Zhang, H, 2018) |
| "The combined prophylactic strategy of sodium bicarbonate plus N-acetylsyteine (NAC) seems to be effective in preventing contrast induced acute kidney injury (CI-AKI) in patients at low-to-medium risk." | 6.25 | Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design. ( Briguori, C; Condorelli, G; Ricciardelli, B; Visconti, G, 2011) |
| "Iso-osmolar Iodixanol is associated with a lower rate of contrast-induced acute kidney injury (CI-AKI) in patients at increased risk compared to low-osmolar contrast media (LOCM)." | 4.93 | Economic impact of contrast-induced acute kidney injury associated with invasive cardiology: role of iso-osmolar contrast media in Germany, Italy, Poland, and Spain. ( De Francesco, M; Hernández, F; Lamotte, M; Ronco, C; Wacinski, PJ; Wessely, R, 2016) |
| "To evaluate iodixanol-associated acute kidney injury (AKI) and prognosis in patients undergoing elective percutaneous coronary intervention (PCI)." | 4.31 | Iodixanol-associated acute kidney injury and prognosis in patients undergoing elective percutaneous coronary intervention: a prospective, multi-center study. ( Azzalini, L; Chen, Z; Huang, L; Jiang, Y; Mao, Q; Xiang, L; Zhao, N; Zhao, X; Zhou, D, 2023) |
| "Iodixanol is associated with lower rates of contrast-induced acute kidney injury (CI-AKI)." | 4.02 | Effects of a High Dose of the Contrast Medium Iodixanol on Renal Function in Patients Following Percutaneous Coronary Intervention. ( Azzalini, L; Chen, Z; Huang, L; Jin, J; Li, L; Mao, Q; Song, Y; Tong, W; Xu, Q; Xu, Z; Zhao, N; Zhao, X; Zhou, Y, 2021) |
| "The aim of this study was to investigate clinical (contrast-induced acute kidney injury [CI-AKI]) and subclinical CI-AKI (SCI-AKI) after intra-arterial administration of Iodixanol and Iopamidol in patients with an estimated glomerular filtration rate (eGFR) ≥60 mL/min/1." | 3.96 | Subclinical Contrast-Induced Acute Kidney Injury in Patients Undergoing Cerebral Computed Tomography. ( Ankawi, G; Biolo, G; Breglia, A; Brocca, A; Carta, M; De Cal, M; Giavarina, D; Godi, I; Guglielmetti, G; Iannucci, G; Passannante, A; Ronco, C; Virzì, GM; Yun, X, 2020) |
| "To determine the incidence of post-contrast acute kidney injury (PC-AKI) and presumed contrast-induced acute kidney injury (CI-AKI) following contrast-enhanced CT (CECT) with intravenous application of a reduced dose of the iso-osmolar contrast agent iodixanol in cancer patients with chronic kidney disease." | 3.96 | Incidence of contrast-induced acute kidney injury (CI-AKI) in high-risk oncology patients undergoing contrast-enhanced CT with a reduced dose of the iso-osmolar iodinated contrast medium iodixanol. ( Bez, C; Hinterleitner, C; Horger, M; Werner, S, 2020) |
| " Rats were treated with Iodixanol to prepare a contrast-induced acute kidney injury (CIAKI) model." | 3.96 | Rapamycin improves renal injury induced by Iodixanol in diabetic rats by deactivating the mTOR/p70S6K signaling pathway. ( Pang, T; Ren, K; Wang, Y; Zhang, H; Zuo, Z, 2020) |
| "In this study, we tested the hypothesis that fasudil, a Rho kinase inhibitor, would protect against contrast-induced acute kidney injury (CI-AKI) in a mouse model and attempted to elucidate the mechanism involved." | 3.88 | Rho Kinase Inhibitor, Fasudil, Attenuates Contrast-induced Acute Kidney Injury. ( Miao, D; Wang, Y; Yang, Z; Zhang, D; Zhang, H, 2018) |
| "Rats received nitric oxide synthase inhibitor L-NAME (10 mg/kg) and cyclooxygenase inhibitor indomethacin (10 mg/kg) to induce the risk for developing iodinated contrast-induced acute kidney injury before receiving one of the interventions: NAC, furosemide, or placebo." | 3.80 | Efficacy of preventive interventions for iodinated contrast-induced acute kidney injury evaluated by intrarenal oxygenation as an early marker. ( Franklin, T; Li, LP; Lu, J; Papadopoulou, MV; Prasad, PV; Solomon, R; Thacker, J; Zhou, Y, 2014) |
| "To compare the incidence of contrast medium-induced acute kidney injury (AKI) after intravenous (IV) administration of iodixanol for computed tomographic (CT) angiography versus intraarterial (IA) injection of iodixanol or low osmolar contrast medium (LOCM) for digital subtraction angiography (DSA) within the same population suspected of peripheral arterial occlusive disease (PAOD)." | 3.77 | Contrast medium-induced acute kidney injury: comparison of intravenous and intraarterial administration of iodinated contrast medium. ( Dohad, SY; Karlsberg, RP; Sheng, R, 2011) |
| " The secondary endpoints were the mean peak SCr increase within 72 h after receiving CM and major adverse renal events (SCr increased by two times after 30 days, the need for dialysis treatment, rehospitalization for acute renal failure, or kidney-related death) during hospitalization and within 30 day postdischarge." | 2.87 | Nephrotoxicity of iodixanol versus iopamidol in patients undergoing peripheral angiography with or without endovascular therapy. ( Che, WQ; Chen, Y; Dong, H; Gao, RL; Jiang, XJ; Peng, M; Xiong, HL; Xu, B; Yang, YJ; Zou, YB, 2018) |
| " The secondary endpoints are absolute and relative increases in sCr of at least 50%, thrombolysis in myocardial infarction (TIMI) perfusion grade, and major adverse cardiac events at 1, 6, and 12 months." | 2.75 | The contrast media and nephrotoxicity following coronary revascularization by primary angioplasty for acute myocardial infarction study: design and rationale of the CONTRAST-AMI study. ( Angioli, P; Bolognese, L; Carrera, A; Ducci, K; Falsini, G; Grotti, S; Liistro, F; Limbruno, U; Picchi, A; Pierli, C, 2010) |
| "The relationship of contrast-induced nephropathy (CIN) to long-term adverse events (AEs) is controversial." | 2.74 | Contrast-induced nephropathy and long-term adverse events: cause and effect? ( Barrett, BJ; Doucet, S; Gelormini, JL; Katholi, RE; Labinaz, M; Mehran, R; Natarajan, MK; Sharma, SK; Solomon, RJ; Staniloae, CS, 2009) |
| "Iodixanol was cost-effective compared with iohexol, with both lower costs and better effects related to fewer adverse drug reactions." | 2.71 | Cost-effectiveness of iodixanol in patients at high risk of contrast-induced nephropathy. ( Aspelin, P; Aubry, P; Fransson, SG; Lundkvist, J; Strasser, R; Willenbrock, R, 2005) |
| "Contrast media can cause acute renal failure by direct toxic effects on the tubular cells and kidney ischemia." | 2.48 | Cost-effectiveness of iso- versus low-osmolality contrast media in outpatients with high risk of contrast medium-induced nephropathy. ( Chicaíza-Becerra, LA; Gamboa, Ó; García-Molina, M, 2012) |
| "Contrast-induced acute kidney injury is a prominent complication following cardiac catheterization, though the risk has progressively decreased in recent times with appropriate risk stratification and use of safer contrast agents." | 1.48 | Are iso-osmolar, as compared to low-osmolar, contrast media cost-effective in patients undergoing cardiac catheterization? An economic analysis. ( Akbari, A; Chow, BJW; Hiremath, S; Wells, GA, 2018) |
| "Inclusion criteria were STEMI patients taken for cardiac catheterization, excluding patients receiving hemodialysis due to end-stage renal disease (ESRD)." | 1.43 | The incidence and significance of acute kidney injury following emergent contrast administration in patients with STEMI and stroke. ( Allen, BR; Elie, MC; Marchick, MR; Shuster, JJ; Weeks, EC, 2016) |
| "Iodixanol treatment of tubules significantly increased the concentration of Apn A (n = 3-5) in the supernatant." | 1.42 | Diadenosine pentaphosphate modulates glomerular arteriolar tone and glomerular filtration rate. ( Carlström, M; Flöge, J; Heintz, B; Jankowski, J; Jankowski, V; Lai, EY; Liu, ZZ; Patzak, A; Sällström, J; Sendeski, MM, 2015) |
| "More necrosis was present after incubation with iohexol and iopamidol than after incubation with equal concentrations of iodixanol." | 1.40 | Exposure to low- vs iso-osmolar contrast agents reduces NADPH-dependent reactive oxygen species generation in a cellular model of renal injury. ( Cafiero, C; Gesualdo, L; Grandaliano, G; Montemurno, E; Netti, GS; Prattichizzo, C; Ranieri, E; Rascio, F; Simone, S; Stallone, G, 2014) |
| " CM increased superoxide concentration and reduced nitric oxide bioavailability in TAL." | 1.40 | Iodinated contrast media cause direct tubular cell damage, leading to oxidative stress, low nitric oxide, and impairment of tubuloglomerular feedback. ( Cantow, K; Liu, R; Liu, ZZ; Lu, Y; Nikitina, T; Patzak, A; Perlewitz, A; Persson, PB; Schmerbach, K; Seeliger, E; Sendeski, MM, 2014) |
| "upon iodixanol injection was reduced almost to the level of iopromide when injecting iodixanol/mannitol (iopromide: 289 ± 68 HU vs iodixanol/mannitol: 343 ± 68 HU)." | 1.38 | The osmolality of nonionic, iodinated contrast agents as an important factor for renal safety. ( Ellinghaus, P; Ernst, R; Jost, G; Lengsfeld, P; Lenhard, DC; Pietsch, H; Sieber, MA, 2012) |
| "The odds ratio of acute kidney failure on day 5 was 0." | 1.38 | Effect of renin-angiotensin-aldosterone system blockade therapy on incidence of contrast-induced nephropathy in patients with chronic kidney disease. ( Ghahramani, N; Lapsiwala, A; Parhizgar, A; Saadulla, L; Spatz, C, 2012) |
| "Postoperative acute renal failure (ARF) is not uncommon after cardiac surgery and after angiography." | 1.35 | Influence of the timing of cardiac catheterization and the amount of contrast media on acute renal failure after cardiac surgery. ( Ballotta, A; Bossone, E; Conti, D; De Benedetti, D; Kandil, H; Kunkl, A; Mehta, RH; Mollichelli, N; Ranucci, M, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (1.09) | 18.2507 |
| 2000's | 19 (20.65) | 29.6817 |
| 2010's | 61 (66.30) | 24.3611 |
| 2020's | 11 (11.96) | 2.80 |
| Authors | Studies |
|---|---|
| Ran, F | 1 |
| Yang, Y | 1 |
| Yang, L | 1 |
| Chen, S | 1 |
| He, P | 1 |
| Liu, Q | 1 |
| Zou, Q | 1 |
| Wang, D | 1 |
| Hou, J | 1 |
| Wang, P | 1 |
| Cheng, L | 1 |
| Wang, L | 1 |
| Chen, B | 1 |
| Wang, C | 1 |
| Wang, M | 1 |
| Li, J | 1 |
| Gao, X | 1 |
| Zhang, Z | 1 |
| Han, L | 1 |
| Chen, Z | 3 |
| Mao, Q | 2 |
| Xiang, L | 1 |
| Zhou, D | 1 |
| Jiang, Y | 1 |
| Zhao, N | 3 |
| Huang, L | 2 |
| Azzalini, L | 3 |
| Zhao, X | 3 |
| Zhang, Y | 1 |
| Zhao, R | 1 |
| Hami, M | 1 |
| Bigdeli, A | 1 |
| Khameneh Bagheri, R | 1 |
| Rajabi, O | 1 |
| Salehi, M | 1 |
| Zahedi Avval, F | 1 |
| Li, Y | 1 |
| Huang, J | 1 |
| He, S | 1 |
| Lu, Z | 1 |
| Zhang, J | 1 |
| Li, X | 1 |
| Yang, Z | 2 |
| Hoffman, RM | 1 |
| Wu, Q | 1 |
| Breglia, A | 1 |
| Godi, I | 1 |
| Virzì, GM | 1 |
| Guglielmetti, G | 1 |
| Iannucci, G | 1 |
| De Cal, M | 1 |
| Brocca, A | 1 |
| Carta, M | 1 |
| Giavarina, D | 1 |
| Ankawi, G | 1 |
| Passannante, A | 1 |
| Yun, X | 1 |
| Biolo, G | 1 |
| Ronco, C | 3 |
| Sharma, A | 1 |
| Kilari, S | 1 |
| Cai, C | 1 |
| Simeon, ML | 1 |
| Misra, S | 2 |
| Werner, S | 1 |
| Bez, C | 1 |
| Hinterleitner, C | 1 |
| Horger, M | 1 |
| Wang, Y | 3 |
| Zhang, H | 3 |
| Pang, T | 1 |
| Zuo, Z | 1 |
| Ren, K | 3 |
| Zhou, Y | 3 |
| Xu, Q | 1 |
| Xu, Z | 1 |
| Tong, W | 1 |
| Li, L | 1 |
| Song, Y | 1 |
| Jin, J | 1 |
| Suh, K | 1 |
| Kellum, JA | 1 |
| Kane-Gill, SL | 1 |
| Miao, D | 1 |
| Zhang, D | 1 |
| Takahashi, EA | 1 |
| Kallmes, DF | 2 |
| Fleming, CJ | 1 |
| McDonald, RJ | 2 |
| McKusick, MA | 1 |
| Bjarnason, H | 1 |
| Harmsen, WS | 1 |
| Keuffel, E | 1 |
| McCullough, PA | 4 |
| Todoran, TM | 1 |
| Brilakis, ES | 1 |
| Palli, SR | 1 |
| Ryan, MP | 1 |
| Gunnarsson, C | 1 |
| Tecson, KM | 1 |
| Brown, D | 1 |
| Choi, JW | 1 |
| Feghali, G | 1 |
| Gonzalez-Stawinski, GV | 1 |
| Hamman, BL | 1 |
| Hebeler, R | 1 |
| Lander, SR | 1 |
| Lima, B | 1 |
| Potluri, S | 1 |
| Schussler, JM | 1 |
| Stoler, RC | 1 |
| Velasco, C | 1 |
| Lei, R | 1 |
| Zhao, F | 2 |
| Tang, CY | 2 |
| Luo, M | 2 |
| Yang, SK | 1 |
| Cheng, W | 2 |
| Li, XW | 2 |
| Duan, SB | 2 |
| Hiremath, S | 1 |
| Akbari, A | 1 |
| Wells, GA | 1 |
| Chow, BJW | 1 |
| Xiong, HL | 1 |
| Peng, M | 1 |
| Jiang, XJ | 1 |
| Dong, H | 2 |
| Che, WQ | 1 |
| Chen, Y | 1 |
| Zou, YB | 1 |
| Xu, B | 1 |
| Yang, YJ | 1 |
| Gao, RL | 1 |
| Vilca, LM | 1 |
| Lombardo, F | 1 |
| Poletti, E | 1 |
| Laricchia, A | 1 |
| Beneduce, A | 1 |
| Maccagni, D | 1 |
| Demir, OM | 1 |
| Slavich, M | 1 |
| Giannini, F | 1 |
| Carlino, M | 2 |
| Margonato, A | 1 |
| Cappelletti, A | 1 |
| Colombo, A | 2 |
| Gerk, U | 1 |
| Franke, RP | 2 |
| Krüger-Genge, A | 2 |
| Jung, F | 2 |
| Kofman, N | 1 |
| Margolis, G | 1 |
| Gal-Oz, A | 1 |
| Letourneau-Shesaf, S | 1 |
| Keren, G | 1 |
| Rozenbaum, Z | 1 |
| Shacham, Y | 1 |
| Castaldo, P | 1 |
| Frascà, GM | 1 |
| Brigante, F | 1 |
| Ferrante, L | 1 |
| Magi, S | 1 |
| Pavani, M | 1 |
| Skrami, E | 1 |
| Giuseppetti, GM | 1 |
| Polonara, G | 1 |
| Amoroso, S | 1 |
| Wang, Z | 1 |
| Zhang, X | 1 |
| Hua, Z | 1 |
| Xie, L | 1 |
| Jiang, X | 1 |
| Wang, R | 1 |
| Gao, P | 1 |
| Lamby, P | 1 |
| Mrowietz, C | 1 |
| Falter, J | 1 |
| Graf, S | 1 |
| Schellenberg, EL | 1 |
| Prantl, L | 1 |
| Hill, M | 1 |
| Mor, MK | 1 |
| Travis, L | 1 |
| Ward, T | 1 |
| Palevsky, PM | 1 |
| Ramkumar, M | 1 |
| Weisbord, SD | 2 |
| Limbruno, U | 3 |
| Picchi, A | 3 |
| Micheli, A | 1 |
| Calabria, P | 1 |
| Cortese, B | 1 |
| Brizi, G | 1 |
| Severi, S | 1 |
| De Caterina, R | 1 |
| Seeliger, E | 2 |
| Cantow, K | 2 |
| Arakelyan, K | 1 |
| Ladwig, M | 1 |
| Persson, PB | 2 |
| Flemming, B | 1 |
| Netti, GS | 1 |
| Prattichizzo, C | 1 |
| Montemurno, E | 1 |
| Simone, S | 1 |
| Cafiero, C | 1 |
| Rascio, F | 1 |
| Stallone, G | 1 |
| Ranieri, E | 1 |
| Grandaliano, G | 1 |
| Gesualdo, L | 1 |
| Liu, ZZ | 2 |
| Schmerbach, K | 1 |
| Lu, Y | 1 |
| Perlewitz, A | 1 |
| Nikitina, T | 1 |
| Patzak, A | 2 |
| Liu, R | 1 |
| Sendeski, MM | 2 |
| Maioli, M | 2 |
| Toso, A | 2 |
| Leoncini, M | 2 |
| Musilli, N | 1 |
| Bellandi, F | 2 |
| Rosner, MH | 1 |
| Li, LP | 2 |
| Lu, J | 2 |
| Papadopoulou, MV | 2 |
| Franklin, T | 2 |
| Bokhary, U | 1 |
| Solomon, R | 3 |
| Sen, A | 1 |
| Prasad, PV | 2 |
| Thacker, J | 1 |
| Wang, YC | 1 |
| Tang, A | 1 |
| Chang, D | 1 |
| Zhang, SJ | 1 |
| Ju, S | 1 |
| Chua, HR | 1 |
| Horrigan, M | 1 |
| Mcintosh, E | 1 |
| Bellomo, R | 1 |
| Schmalfuss, CM | 1 |
| Woodard, PK | 1 |
| Gitter, MJ | 1 |
| Jadhav, MP | 1 |
| Bellinger, RL | 1 |
| Rose, SC | 1 |
| Bavry, AA | 1 |
| Choi, MJ | 1 |
| Yoon, JW | 1 |
| Han, SJ | 1 |
| Choi, HH | 1 |
| Song, YR | 1 |
| Kim, SG | 1 |
| Oh, JE | 1 |
| Lee, YK | 1 |
| Seo, JW | 1 |
| Kim, HJ | 1 |
| Noh, JW | 1 |
| Koo, JR | 1 |
| McDonald, JS | 1 |
| Carter, RE | 1 |
| Hartman, RP | 1 |
| Katzberg, RW | 1 |
| Williamson, EE | 1 |
| Mariani, J | 1 |
| Guedes, C | 1 |
| Soares, P | 1 |
| Zalc, S | 1 |
| Campos, CM | 1 |
| Lopes, AC | 1 |
| Spadaro, AG | 1 |
| Perin, MA | 1 |
| Filho, AE | 1 |
| Takimura, CK | 1 |
| Ribeiro, E | 1 |
| Kalil-Filho, R | 1 |
| Edelman, ER | 1 |
| Serruys, PW | 1 |
| Lemos, PA | 1 |
| Carlström, M | 1 |
| Lai, EY | 1 |
| Sällström, J | 1 |
| Flöge, J | 1 |
| Heintz, B | 1 |
| Jankowski, J | 1 |
| Jankowski, V | 1 |
| Liu, TQ | 1 |
| Luo, WL | 1 |
| Tan, X | 1 |
| Fang, Y | 1 |
| Chen, J | 1 |
| Yu, XF | 1 |
| Cai, JR | 1 |
| Ding, XQ | 1 |
| Danziger, J | 1 |
| Thummalakunta, L | 1 |
| Nelson, R | 1 |
| Faintuch, S | 1 |
| Yao, L | 1 |
| Zhao, CX | 1 |
| Gu, X | 1 |
| Tan, TW | 1 |
| Hamidian Jahromi, A | 1 |
| Zhang, WW | 1 |
| Kobalava, ZD | 1 |
| Villevalde, SV | 1 |
| Gaskina, AA | 1 |
| Mayskov, VV | 1 |
| Moiseev, VS | 1 |
| Quintavalle, C | 1 |
| Anselmi, CV | 1 |
| De Micco, F | 1 |
| Roscigno, G | 1 |
| Visconti, G | 2 |
| Golia, B | 1 |
| Focaccio, A | 2 |
| Ricciardelli, B | 3 |
| Perna, E | 1 |
| Papa, L | 1 |
| Donnarumma, E | 1 |
| Condorelli, G | 3 |
| Briguori, C | 3 |
| Shema-Didi, L | 1 |
| Kristal, B | 1 |
| Eizenberg, S | 1 |
| Marzuq, N | 1 |
| Sussan, M | 1 |
| Feldman-Idov, Y | 1 |
| Ofir, P | 1 |
| Atar, S | 1 |
| Barbanti, M | 1 |
| Gulino, S | 1 |
| Capranzano, P | 1 |
| Immè, S | 1 |
| Sgroi, C | 1 |
| Tamburino, C | 2 |
| Ohno, Y | 1 |
| Attizzani, GF | 1 |
| Patanè, M | 1 |
| Sicuso, R | 1 |
| Pilato, G | 1 |
| Di Landro, A | 1 |
| Todaro, D | 1 |
| Di Simone, E | 1 |
| Picci, A | 1 |
| Giannetto, G | 1 |
| Costa, G | 1 |
| Deste, W | 1 |
| Giannazzo, D | 1 |
| Grasso, C | 1 |
| Capodanno, D | 1 |
| De Francesco, M | 1 |
| Wacinski, PJ | 1 |
| Wessely, R | 1 |
| Hernández, F | 1 |
| Lamotte, M | 1 |
| Giustino, G | 1 |
| Baber, U | 1 |
| Mastoris, I | 1 |
| Vlachojannis, GJ | 1 |
| Yu, J | 1 |
| Teirstein, PS | 1 |
| Downey, WE | 1 |
| Batchelor, WB | 1 |
| Casterella, PJ | 1 |
| Nikolsky, E | 1 |
| Wong, SC | 1 |
| Theodoropoulos, KN | 1 |
| Dangas, GD | 1 |
| Mehran, R | 2 |
| Marchick, MR | 1 |
| Allen, BR | 1 |
| Weeks, EC | 1 |
| Shuster, JJ | 1 |
| Elie, MC | 1 |
| Valero, E | 1 |
| Rodríguez, JC | 1 |
| Moyano, P | 1 |
| Miñana, G | 1 |
| Sanchis, J | 1 |
| Núñez, J | 1 |
| Rezaei, Y | 1 |
| Khademvatani, K | 1 |
| Rahimi, B | 1 |
| Khoshfetrat, M | 1 |
| Arjmand, N | 1 |
| Seyyed-Mohammadzad, MH | 1 |
| Wu, CJ | 1 |
| Bao, ML | 1 |
| Wang, Q | 1 |
| Wang, XN | 1 |
| Liu, XS | 1 |
| Shi, HB | 1 |
| Zhang, YD | 1 |
| Fananapazir, G | 1 |
| Troppmann, C | 1 |
| Corwin, MT | 1 |
| Nikpour, AM | 1 |
| Naderi, S | 1 |
| Lamba, R | 1 |
| Barbieri, L | 1 |
| Verdoia, M | 1 |
| Nardin, M | 1 |
| Marino, P | 1 |
| Suryapranata, H | 1 |
| De Luca, G | 1 |
| Sanon, S | 1 |
| Barsness, GW | 1 |
| Gulati, R | 1 |
| Nie, B | 1 |
| Cheng, WJ | 1 |
| Li, YF | 1 |
| Cao, Z | 1 |
| Yang, Q | 1 |
| Zhao, YX | 1 |
| Guo, YH | 1 |
| Zhou, YJ | 1 |
| Heinrich, MC | 1 |
| Häberle, L | 1 |
| Müller, V | 1 |
| Bautz, W | 1 |
| Uder, M | 1 |
| Chuang, FR | 1 |
| Chen, TC | 1 |
| Wang, IK | 1 |
| Chuang, CH | 1 |
| Chang, HW | 1 |
| Ting-Yu Chiou, T | 1 |
| Cheng, YF | 1 |
| Lee, WC | 1 |
| Chen, WC | 1 |
| Yang, KD | 1 |
| Lee, CH | 1 |
| Agrawal, V | 1 |
| Swami, A | 1 |
| Kosuri, R | 1 |
| Alsabbagh, M | 1 |
| Agarwal, M | 1 |
| Samarapungavan, D | 1 |
| Rocher, LL | 1 |
| Solomon, RJ | 1 |
| Natarajan, MK | 1 |
| Doucet, S | 1 |
| Katholi, RE | 1 |
| Staniloae, CS | 1 |
| Sharma, SK | 1 |
| Labinaz, M | 1 |
| Gelormini, JL | 1 |
| Barrett, BJ | 1 |
| Capasso, P | 1 |
| Vasheghani-Farahani, A | 1 |
| Sadigh, G | 1 |
| Kassaian, SE | 1 |
| Khatami, SM | 1 |
| Fotouhi, A | 1 |
| Razavi, SA | 1 |
| Mansournia, MA | 1 |
| Yamini-Sharif, A | 1 |
| Amirzadegan, A | 1 |
| Salarifar, M | 1 |
| Sadeghian, S | 1 |
| Davoodi, G | 1 |
| Borumand, MA | 1 |
| Esfehani, FA | 1 |
| Darabian, S | 1 |
| Bolognese, L | 2 |
| Falsini, G | 2 |
| Grotti, S | 2 |
| Liistro, F | 2 |
| Carrera, A | 2 |
| Angioli, P | 2 |
| Ducci, K | 2 |
| Pierli, C | 2 |
| Gallopin, M | 1 |
| Tedeschi, D | 1 |
| Micheletti, C | 1 |
| Cho, JY | 1 |
| Jeong, MH | 1 |
| Hwan Park, S | 1 |
| Kim, IS | 1 |
| Park, KH | 1 |
| Sim, DS | 1 |
| Yoon, NS | 1 |
| Yoon, HJ | 1 |
| Park, HW | 1 |
| Hong, YJ | 1 |
| Kim, JH | 1 |
| Ahn, Y | 1 |
| Cho, JG | 1 |
| Park, JC | 1 |
| Kang, JC | 1 |
| Matejka, J | 1 |
| Varvarovsky, I | 1 |
| Vojtisek, P | 1 |
| Herman, A | 1 |
| Rozsival, V | 1 |
| Borkova, V | 1 |
| Kvasnicka, J | 1 |
| Reed, MC | 1 |
| Moscucci, M | 1 |
| Smith, DE | 1 |
| Share, D | 1 |
| LaLonde, T | 1 |
| Mahmood, SA | 1 |
| D'Haem, C | 1 |
| McNamara, R | 1 |
| Greenbaum, A | 1 |
| Gurm, HS | 1 |
| Serafin, Z | 1 |
| Karolkiewicz, M | 1 |
| Gruszka, M | 1 |
| Strózecki, P | 1 |
| Lasek, W | 1 |
| Odrowaz-Sypniewska, G | 1 |
| Manitius, J | 1 |
| Beuth, W | 1 |
| Karlsberg, RP | 1 |
| Dohad, SY | 1 |
| Sheng, R | 1 |
| Wi, J | 1 |
| Ko, YG | 1 |
| Kim, JS | 1 |
| Kim, BK | 1 |
| Choi, D | 1 |
| Ha, JW | 1 |
| Hong, MK | 1 |
| Jang, Y | 1 |
| Schwenke, C | 1 |
| Lenhard, DC | 1 |
| Pietsch, H | 1 |
| Sieber, MA | 1 |
| Ernst, R | 1 |
| Lengsfeld, P | 1 |
| Ellinghaus, P | 1 |
| Jost, G | 1 |
| Spatz, C | 1 |
| Saadulla, L | 1 |
| Lapsiwala, A | 1 |
| Parhizgar, A | 1 |
| Ghahramani, N | 1 |
| Chicaíza-Becerra, LA | 1 |
| García-Molina, M | 1 |
| Gamboa, Ó | 1 |
| Ludwig, U | 1 |
| Connemann, J | 1 |
| Keller, F | 1 |
| Boccalandro, F | 1 |
| Amhad, M | 1 |
| Smalling, RW | 1 |
| Sdringola, S | 1 |
| Dean, LS | 1 |
| Aspelin, P | 1 |
| Aubry, P | 1 |
| Fransson, SG | 1 |
| Strasser, R | 1 |
| Willenbrock, R | 1 |
| Lundkvist, J | 1 |
| Cowburn, PJ | 1 |
| Patel, H | 1 |
| Pipes, RR | 1 |
| Parker, JD | 1 |
| Sherwin, PF | 1 |
| Cambron, R | 1 |
| Johnson, JA | 1 |
| Pierro, JA | 1 |
| Airoldi, F | 1 |
| Morici, N | 1 |
| Sangiorgi, GM | 1 |
| Violante, A | 1 |
| Montorfano, M | 1 |
| Valente, S | 1 |
| Lazzeri, C | 1 |
| Giglioli, C | 1 |
| Margheri, M | 1 |
| Comeglio, M | 1 |
| Nicolaci, L | 1 |
| Chechi, T | 1 |
| Gensini, GF | 1 |
| Deray, G | 1 |
| Persson, P | 1 |
| Liss, P | 1 |
| Hansell, P | 1 |
| Möckel, M | 1 |
| Radovic, M | 1 |
| Kühnle, Y | 1 |
| Combé, V | 1 |
| Waigand, J | 1 |
| Schröder, S | 1 |
| Dietz, R | 1 |
| Frei, U | 1 |
| Eckardt, KU | 1 |
| Ranucci, M | 1 |
| Ballotta, A | 1 |
| Kunkl, A | 1 |
| De Benedetti, D | 1 |
| Kandil, H | 1 |
| Conti, D | 1 |
| Mollichelli, N | 1 |
| Bossone, E | 1 |
| Mehta, RH | 1 |
| Jakobsen, JA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Timing of Coronary Angiography and Multivariate Risk for Cardiac Surgery Associated Acute Kidney Injury and Major Adverse Renal and Cardiac Events (MARCE)[NCT02332070] | 965 participants (Actual) | Observational | 2015-01-31 | Completed | |||
| Contrast-inDuced nephRotoxicity as Assessed by the Cystatin-modified KIdney Load-to-DAmage RElationship[NCT01908309] | Early Phase 1 | 150 participants (Actual) | Interventional | 2013-04-30 | Completed | ||
| Personalized Versus Standard Hydration for Prevention of Contrast Induced Acute Kidney Injury. A Randomized Trial With Bioimpedance Analysis.[NCT02225431] | Phase 4 | 296 participants (Actual) | Interventional | 2012-09-30 | Completed | ||
| Prevention of Contrast-Induced Acute Kidney Injury: Standard Versus Short Hydration Protocol in Patients With Normal Fluid Status Assessed by the Bioimpedance Analysis (The HYDRA II Study)[NCT04215042] | 1,000 participants (Anticipated) | Interventional | 2016-05-01 | Recruiting | |||
| Functional MRI-based Assessment of Terlipressin vs. Octreotide on Renal Function in Cirrhotic Patients With Acute Variceal Bleeding (CHESS1903): A Multicenter, Single-blind, Randomised Controlled Trial[NCT04028323] | Phase 4 | 60 participants (Anticipated) | Interventional | 2019-07-16 | Recruiting | ||
| Intravenous vs. Oral Hydration to Reduce the Risk of Post-Contrast Acute Kidney Injury After Intravenous Contrast-Enhanced Computed Tomography in Patients With Severe Chronic Kidney Disease (ENRICH): A Randomized Controlled Trial[NCT05283512] | 254 participants (Anticipated) | Interventional | 2022-04-20 | Recruiting | |||
| Renal Insufficiency Following Contrast Media Administration Trial IV: Contrast Media Volume Control for Limiting Contrast-Induced Acute Kidney in Acute Coronary Syndrome.[NCT04714736] | 522 participants (Anticipated) | Interventional | 2020-02-10 | Recruiting | |||
| Minimizing cOntrast utiliZAtion With IVUS Guidance in coRonary angioplasTy: The MOZART Study[NCT01947335] | Phase 4 | 83 participants (Actual) | Interventional | 2012-11-30 | Completed | ||
| IVUS Based Ultra-low Volume Contrast Media PCI to Reduce Contrast Induced Nephrology in Patient With Chronic Kidney disease-a Multi-center, Open Label, Randomized Trial (IVUS-CKD)[NCT05913362] | 320 participants (Anticipated) | Interventional | 2023-10-01 | Not yet recruiting | |||
| Renal Insufficiency Following Contrast Media Administration Trial II (Remedial II): The RenalGuard System in High-Risk Patients for Contrast-Induced Acute Kidney Injury[NCT01098032] | Phase 3 | 294 participants (Actual) | Interventional | 2009-01-31 | Completed | ||
| [NCT02070679] | Phase 3 | 284 participants (Actual) | Interventional | 2014-02-28 | Completed | ||
| Antioxidants for Preventing Contrast-Induced Acute Kidney Injury After Coronary Artery Catheterization[NCT03755700] | Phase 3 | 1,000 participants (Anticipated) | Interventional | 2018-11-01 | Recruiting | ||
| CARE (Visipaque 320 and Isovue 370 in Cardiac Angiography in REnally Impaired Patients); FOLLOW-UP STUDY[NCT00479024] | 294 participants (Actual) | Observational | 2007-06-30 | Completed | |||
| Effectiveness of Remote Ischemic Preconditioning for Prevention of Contrast Induced Acute Kidney Injury in Patients Undergoing Coronary Angiograms.[NCT05147831] | 300 participants (Anticipated) | Interventional | 2021-11-30 | Recruiting | |||
| The Contrast Media and Nephrotoxicity Following Coronary Revascularization by Primary Angioplasty for Acute Myocardial Infarction. The CONTRAST-AMI Study.[NCT00827788] | Phase 4 | 432 participants (Anticipated) | Interventional | 2008-12-31 | Completed | ||
| Department of Geriatrics[NCT02575092] | Phase 2/Phase 3 | 4,000 participants (Actual) | Interventional | 2015-11-01 | Completed | ||
| Predictive Value of CHA2DS2-VASC Score and Contrast Volume to Creatinine Clearance Ratio in Relation to Mehran Score for Contrast-Induced Nephropathy In ST- Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention[NCT03266458] | 210 participants (Anticipated) | Observational [Patient Registry] | 2018-01-01 | Not yet recruiting | |||
| High Dose Atorvastatin Raises Threshold of Contrast Induced Nephropathy in Diabetic Patients Undergoing Elective Coronary Intervention[NCT04375787] | Phase 4 | 200 participants (Actual) | Interventional | 2020-03-15 | Completed | ||
| Evaluation of the Effect of Dapagliflozin on Cardiac Remodeling in Post Myocardial Infarction Patients[NCT05335629] | 60 participants (Anticipated) | Interventional | 2022-09-01 | Recruiting | |||
| BIcarbonato di Sodio e N-Acetilcisteina Nella Prevenzione Della Nefropatia da Mezzo di Contrasto Nell'infaRto mIocardico acutO(Registro BINARIO)[NCT01218178] | 520 participants (Actual) | Observational | 2008-06-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Increase >= 0.5 mg/dl in basal serum creatinine (NCT01947335)
Timeframe: 7 days
| Intervention | percentage of participants (Number) |
|---|---|
| Angiography-guided PCI | 19 |
| IVUS-guided PCI | 7.3 |
Total volume of iodine contrast administered during the index procedure. (NCT01947335)
Timeframe: Day 1
| Intervention | ml (Median) |
|---|---|
| Angiography-guided PCI | 64.5 |
| IVUS-guided PCI | 20.0 |
Composite of death, myocardial infarction or repeat revascularization (NCT01947335)
Timeframe: 30 days and 6 months
| Intervention | participants (Number) | |
|---|---|---|
| 30 days | 6-months | |
| Angiography-guided PCI | 2 | 2 |
| IVUS-guided PCI | 2 | 5 |
The primary outcome measure will be the rate of development of CI-AKI in the 2 study arms (number of participants). CI-AKI is defined as an increase in the serum creatinine concentration >=0.3 mg/dL from the baseline value at 48 hours after administration of the contrast media or the need for dialysis. (NCT01098032)
Timeframe: at 48 hours following contrast exposure
| Intervention | participants (Number) |
|---|---|
| Systemic Alone Therapy Group | 146 |
| RenalGuard System Group | 146 |
6 reviews available for iodixanol and Acute Kidney Failure
| Article | Year |
|---|---|
A systematic review of cost-effectiveness analyses across the acute kidney injury landscape.
Topics: Acute Kidney Injury; Biomarkers; Contrast Media; Cost-Benefit Analysis; Humans; Iohexol; Renal Repla | 2021 |
Economic impact of contrast-induced acute kidney injury associated with invasive cardiology: role of iso-osmolar contrast media in Germany, Italy, Poland, and Spain.
Topics: Acute Kidney Injury; Coronary Angiography; Europe; Humans; Patient Safety; Percutaneous Coronary Int | 2016 |
Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials.
Topics: Acute Kidney Injury; Aged; Cardiac Catheterization; Confidence Intervals; Contrast Media; Creatinine | 2009 |
Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design.
Topics: Acetylcysteine; Acute Kidney Injury; Biomarkers; Chi-Square Distribution; Chronic Disease; Contrast | 2011 |
Cost-effectiveness of iso- versus low-osmolality contrast media in outpatients with high risk of contrast medium-induced nephropathy.
Topics: Acute Kidney Injury; Aged; Colombia; Contrast Media; Cost-Benefit Analysis; Decision Trees; Drug Cos | 2012 |
The role of osmolality in the incidence of contrast-induced nephropathy: a systematic review of angiographic contrast media in high risk patients.
Topics: Acute Kidney Injury; Contrast Media; Humans; Incidence; Iohexol; Kidney Failure, Chronic; Osmolar Co | 2005 |
21 trials available for iodixanol and Acute Kidney Failure
| Article | Year |
|---|---|
The effect of curcumin in prevention of contrast nephropathy following coronary angiography or angioplasty in CKD patients.
Topics: Acute Kidney Injury; Administration, Oral; Angioplasty; Antioxidants; Contrast Media; Coronary Angio | 2019 |
Nephrotoxicity of iodixanol versus iopamidol in patients undergoing peripheral angiography with or without endovascular therapy.
Topics: Acute Kidney Injury; Aged; Angiography; Contrast Media; Creatinine; Double-Blind Method; Endovascula | 2018 |
Refining the assessment of contrast-induced acute kidney injury: the load-to-damage relationship.
Topics: Acute Kidney Injury; Aged; Contrast Media; Coronary Angiography; Creatinine; Dose-Response Relations | 2014 |
The prevention of contrast-induced nephropathy by simultaneous hemofiltration during coronary angiographic procedures: a comparison with periprocedural hemofiltration.
Topics: Acute Kidney Injury; Aged; Contrast Media; Coronary Angiography; Creatinine; Female; Hemofiltration; | 2014 |
Intravascular ultrasound guidance to minimize the use of iodine contrast in percutaneous coronary intervention: the MOZART (Minimizing cOntrast utiliZation With IVUS Guidance in coRonary angioplasTy) randomized controlled trial.
Topics: Acute Kidney Injury; Aged; Biomarkers; Contrast Media; Coronary Angiography; Coronary Artery Disease | 2014 |
Intravascular ultrasound guidance to minimize the use of iodine contrast in percutaneous coronary intervention: the MOZART (Minimizing cOntrast utiliZation With IVUS Guidance in coRonary angioplasTy) randomized controlled trial.
Topics: Acute Kidney Injury; Aged; Biomarkers; Contrast Media; Coronary Angiography; Coronary Artery Disease | 2014 |
Intravascular ultrasound guidance to minimize the use of iodine contrast in percutaneous coronary intervention: the MOZART (Minimizing cOntrast utiliZation With IVUS Guidance in coRonary angioplasTy) randomized controlled trial.
Topics: Acute Kidney Injury; Aged; Biomarkers; Contrast Media; Coronary Angiography; Coronary Artery Disease | 2014 |
Intravascular ultrasound guidance to minimize the use of iodine contrast in percutaneous coronary intervention: the MOZART (Minimizing cOntrast utiliZation With IVUS Guidance in coRonary angioplasTy) randomized controlled trial.
Topics: Acute Kidney Injury; Aged; Biomarkers; Contrast Media; Coronary Angiography; Coronary Artery Disease | 2014 |
Intravascular ultrasound guidance to minimize the use of iodine contrast in percutaneous coronary intervention: the MOZART (Minimizing cOntrast utiliZation With IVUS Guidance in coRonary angioplasTy) randomized controlled trial.
Topics: Acute Kidney Injury; Aged; Biomarkers; Contrast Media; Coronary Angiography; Coronary Artery Disease | 2014 |
Intravascular ultrasound guidance to minimize the use of iodine contrast in percutaneous coronary intervention: the MOZART (Minimizing cOntrast utiliZation With IVUS Guidance in coRonary angioplasTy) randomized controlled trial.
Topics: Acute Kidney Injury; Aged; Biomarkers; Contrast Media; Coronary Angiography; Coronary Artery Disease | 2014 |
Intravascular ultrasound guidance to minimize the use of iodine contrast in percutaneous coronary intervention: the MOZART (Minimizing cOntrast utiliZation With IVUS Guidance in coRonary angioplasTy) randomized controlled trial.
Topics: Acute Kidney Injury; Aged; Biomarkers; Contrast Media; Coronary Angiography; Coronary Artery Disease | 2014 |
Intravascular ultrasound guidance to minimize the use of iodine contrast in percutaneous coronary intervention: the MOZART (Minimizing cOntrast utiliZation With IVUS Guidance in coRonary angioplasTy) randomized controlled trial.
Topics: Acute Kidney Injury; Aged; Biomarkers; Contrast Media; Coronary Angiography; Coronary Artery Disease | 2014 |
Intravascular ultrasound guidance to minimize the use of iodine contrast in percutaneous coronary intervention: the MOZART (Minimizing cOntrast utiliZation With IVUS Guidance in coRonary angioplasTy) randomized controlled trial.
Topics: Acute Kidney Injury; Aged; Biomarkers; Contrast Media; Coronary Angiography; Coronary Artery Disease | 2014 |
Neutrophil Gelatinase-Associated Lipocalin and Contrast-Induced Acute Kidney Injury.
Topics: Acute Kidney Injury; Acute-Phase Proteins; Aged; Aged, 80 and over; Angiography; Angioplasty; Biomar | 2015 |
Neutrophil Gelatinase-Associated Lipocalin and Contrast-Induced Acute Kidney Injury.
Topics: Acute Kidney Injury; Acute-Phase Proteins; Aged; Aged, 80 and over; Angiography; Angioplasty; Biomar | 2015 |
Neutrophil Gelatinase-Associated Lipocalin and Contrast-Induced Acute Kidney Injury.
Topics: Acute Kidney Injury; Acute-Phase Proteins; Aged; Aged, 80 and over; Angiography; Angioplasty; Biomar | 2015 |
Neutrophil Gelatinase-Associated Lipocalin and Contrast-Induced Acute Kidney Injury.
Topics: Acute Kidney Injury; Acute-Phase Proteins; Aged; Aged, 80 and over; Angiography; Angioplasty; Biomar | 2015 |
Prevention of contrast-induced nephropathy with single bolus erythropoietin in patients with diabetic kidney disease: A randomized controlled trial.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Aged, 80 and over; Biomarkers; Contrast Media; Coronary A | 2016 |
Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement: The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Va
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Aortic Valve; Aortic Valve Stenosis; Cardiac Catheteri | 2015 |
One-year results of the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) Study.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Contrast Media; Corona | 2016 |
Short-Term High-Dose Vitamin E to Prevent Contrast Medium-Induced Acute Kidney Injury in Patients With Chronic Kidney Disease Undergoing Elective Coronary Angiography: A Randomized Placebo-Controlled Trial.
Topics: Acute Kidney Injury; Aged; alpha-Tocopherol; Antioxidants; Biomarkers; Chi-Square Distribution; Cont | 2016 |
Short-Term High-Dose Vitamin E to Prevent Contrast Medium-Induced Acute Kidney Injury in Patients With Chronic Kidney Disease Undergoing Elective Coronary Angiography: A Randomized Placebo-Controlled Trial.
Topics: Acute Kidney Injury; Aged; alpha-Tocopherol; Antioxidants; Biomarkers; Chi-Square Distribution; Cont | 2016 |
Short-Term High-Dose Vitamin E to Prevent Contrast Medium-Induced Acute Kidney Injury in Patients With Chronic Kidney Disease Undergoing Elective Coronary Angiography: A Randomized Placebo-Controlled Trial.
Topics: Acute Kidney Injury; Aged; alpha-Tocopherol; Antioxidants; Biomarkers; Chi-Square Distribution; Cont | 2016 |
Short-Term High-Dose Vitamin E to Prevent Contrast Medium-Induced Acute Kidney Injury in Patients With Chronic Kidney Disease Undergoing Elective Coronary Angiography: A Randomized Placebo-Controlled Trial.
Topics: Acute Kidney Injury; Aged; alpha-Tocopherol; Antioxidants; Biomarkers; Chi-Square Distribution; Cont | 2016 |
A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention.
Topics: Acute Kidney Injury; Aged; Angioplasty, Balloon, Coronary; Cardiovascular Diseases; Contrast Media; | 2008 |
Comparison of iodixanol and iohexol in patients undergoing intravenous pyelography: a prospective controlled study.
Topics: Acute Kidney Injury; Adult; Aged; Contrast Media; Creatinine; Cytokines; Double-Blind Method; Drug E | 2009 |
Contrast-induced nephropathy and long-term adverse events: cause and effect?
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Comorbidity; Contrast Media; Creatinine; Cystatin C; F | 2009 |
Contrast-induced nephropathy and long-term adverse events: cause and effect?
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Comorbidity; Contrast Media; Creatinine; Cystatin C; F | 2009 |
Contrast-induced nephropathy and long-term adverse events: cause and effect?
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Comorbidity; Contrast Media; Creatinine; Cystatin C; F | 2009 |
Contrast-induced nephropathy and long-term adverse events: cause and effect?
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Comorbidity; Contrast Media; Creatinine; Cystatin C; F | 2009 |
Sodium bicarbonate plus isotonic saline versus saline for prevention of contrast-induced nephropathy in patients undergoing coronary angiography: a randomized controlled trial.
Topics: Acute Kidney Injury; Aged; Biomarkers; Contrast Media; Coronary Angiography; Creatinine; Double-Blin | 2009 |
The contrast media and nephrotoxicity following coronary revascularization by primary angioplasty for acute myocardial infarction study: design and rationale of the CONTRAST-AMI study.
Topics: Acetylcysteine; Acute Kidney Injury; Angioplasty, Balloon, Coronary; Biomarkers; Contrast Media; Cor | 2010 |
The contrast media and nephrotoxicity following coronary revascularization by primary angioplasty for acute myocardial infarction study: design and rationale of the CONTRAST-AMI study.
Topics: Acetylcysteine; Acute Kidney Injury; Angioplasty, Balloon, Coronary; Biomarkers; Contrast Media; Cor | 2010 |
The contrast media and nephrotoxicity following coronary revascularization by primary angioplasty for acute myocardial infarction study: design and rationale of the CONTRAST-AMI study.
Topics: Acetylcysteine; Acute Kidney Injury; Angioplasty, Balloon, Coronary; Biomarkers; Contrast Media; Cor | 2010 |
The contrast media and nephrotoxicity following coronary revascularization by primary angioplasty for acute myocardial infarction study: design and rationale of the CONTRAST-AMI study.
Topics: Acetylcysteine; Acute Kidney Injury; Angioplasty, Balloon, Coronary; Biomarkers; Contrast Media; Cor | 2010 |
Prevention of contrast-induced acute kidney injury by theophylline in elderly patients with chronic kidney disease.
Topics: Acute Kidney Injury; Age Factors; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Biomarker | 2010 |
High incidence of nephropathy in neurosurgical patients after intra-arterial administration of low-osmolar and iso-osmolar contrast media.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Contrast Media; Diabetes Complications; Double- | 2011 |
Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design.
Topics: Acetylcysteine; Acute Kidney Injury; Biomarkers; Chi-Square Distribution; Chronic Disease; Contrast | 2011 |
Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast
Topics: Acute Kidney Injury; Aged; Angioplasty, Balloon, Coronary; Contrast Media; Coronary Angiography; Cor | 2012 |
Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast
Topics: Acute Kidney Injury; Aged; Angioplasty, Balloon, Coronary; Contrast Media; Coronary Angiography; Cor | 2012 |
Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast
Topics: Acute Kidney Injury; Aged; Angioplasty, Balloon, Coronary; Contrast Media; Coronary Angiography; Cor | 2012 |
Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast
Topics: Acute Kidney Injury; Aged; Angioplasty, Balloon, Coronary; Contrast Media; Coronary Angiography; Cor | 2012 |
Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast.
Topics: Acetylcysteine; Acute Kidney Injury; Administration, Oral; Aged; Cardiac Catheterization; Contrast M | 2003 |
Cost-effectiveness of iodixanol in patients at high risk of contrast-induced nephropathy.
Topics: Acute Kidney Injury; Angiography; Contrast Media; Coronary Angiography; Cost-Benefit Analysis; Healt | 2005 |
66 other studies available for iodixanol and Acute Kidney Failure
| Article | Year |
|---|---|
Capsaicin Prevents Contrast-Associated Acute Kidney Injury through Activation of Nrf2 in Mice.
Topics: Acute Kidney Injury; Animals; Capsaicin; Contrast Media; Disease Models, Animal; Kidney; Malondialde | 2022 |
A multiple-metabolites model to predict preliminary renal injury induced by iodixanol based on UHPLC/Q-Orbitrap-MS and
Topics: Acute Kidney Injury; Biomarkers; Chromatography, High Pressure Liquid; Humans; Indoles; Kidney; Kynu | 2022 |
Iodixanol-associated acute kidney injury and prognosis in patients undergoing elective percutaneous coronary intervention: a prospective, multi-center study.
Topics: Acute Kidney Injury; Aged; Contrast Media; Humans; Myocardial Infarction; Percutaneous Coronary Inte | 2023 |
Dosing of iodixanol for predicting acute kidney injury in patients undergoing elective percutaneous coronary intervention.
Topics: Acute Kidney Injury; Contrast Media; Creatinine; Humans; Percutaneous Coronary Intervention; Risk Fa | 2023 |
APELA/ELA32 Reduces Iodixanol-induced Apoptosis, Inflammatory Response and Mitochondrial and DNA Damage in Renal Tubular Epithelial Cells.
Topics: Acute Kidney Injury; Apoptosis; Contrast Media; DNA Damage; Epithelial Cells; Humans; Kidney; Mitoch | 2020 |
Subclinical Contrast-Induced Acute Kidney Injury in Patients Undergoing Cerebral Computed Tomography.
Topics: Acute Kidney Injury; Aged; Biomarkers; Brain; Contrast Media; Creatinine; Female; Glomerular Filtrat | 2020 |
Increased fibrotic signaling in a murine model for intra-arterial contrast-induced acute kidney injury.
Topics: Acute Kidney Injury; Animals; Apoptosis; Carotid Arteries; Cell Hypoxia; Cell Proliferation; Collage | 2020 |
Incidence of contrast-induced acute kidney injury (CI-AKI) in high-risk oncology patients undergoing contrast-enhanced CT with a reduced dose of the iso-osmolar iodinated contrast medium iodixanol.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Contrast Media; Female; Humans; Incidence; Male | 2020 |
Rapamycin improves renal injury induced by Iodixanol in diabetic rats by deactivating the mTOR/p70S6K signaling pathway.
Topics: Acute Kidney Injury; Animals; Apoptosis; Autophagy; Diabetes Mellitus, Experimental; Kidney; Male; P | 2020 |
Effects of a High Dose of the Contrast Medium Iodixanol on Renal Function in Patients Following Percutaneous Coronary Intervention.
Topics: Acute Kidney Injury; Aged; Contrast Media; Female; Glomerular Filtration Rate; Humans; Incidence; Ma | 2021 |
Rho Kinase Inhibitor, Fasudil, Attenuates Contrast-induced Acute Kidney Injury.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Acute Kidney Injury; Animals; Apoptosis; Biomarkers; | 2018 |
Predictors and Outcomes of Postcontrast Acute Kidney Injury after Endovascular Renal Artery Intervention.
Topics: Acute Kidney Injury; Aged; Computed Tomography Angiography; Contrast Media; Female; Follow-Up Studie | 2017 |
The effect of major adverse renal cardiovascular event (MARCE) incidence, procedure volume, and unit cost on the hospital savings resulting from contrast media use in inpatient angioplasty.
Topics: Acute Kidney Injury; Angioplasty; Budgets; Contrast Media; Costs and Cost Analysis; Female; Heart Di | 2018 |
Major Adverse Renal and Cardiac Events After Coronary Angiography and Cardiac Surgery.
Topics: Acute Kidney Injury; Aged; Cardiac Surgical Procedures; Cohort Studies; Confidence Intervals; Contra | 2018 |
Mitophagy Plays a Protective Role in Iodinated Contrast-Induced Acute Renal Tubular Epithelial Cells Injury.
Topics: Acute Kidney Injury; Adenine; Apoptosis; Autophagy; Cell Line; Contrast Media; Epithelial Cells; Hum | 2018 |
Are iso-osmolar, as compared to low-osmolar, contrast media cost-effective in patients undergoing cardiac catheterization? An economic analysis.
Topics: Acute Kidney Injury; Canada; Cardiac Catheterization; Contrast Media; Coronary Angiography; Cost-Ben | 2018 |
Comparison of iohexol and iodixanol induced nephrotoxicity, mitochondrial damage and mitophagy in a new contrast-induced acute kidney injury rat model.
Topics: Acute Kidney Injury; Animals; Contrast Media; Disease Models, Animal; Iohexol; Kidney Function Tests | 2018 |
Incidence of contrast-induced acute kidney injury in a large cohort of all-comers undergoing percutaneous coronary intervention: Comparison of five contrast media.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Cohort Studies; Contrast Media; Female; Humans; Incide | 2018 |
Acute effects of Iodixanol on renal function after intra-arterial administration in patients with end-stage kidney disease.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Contrast Media; Female; Humans; Kidney Failure, Chroni | 2018 |
Long-term renal outcomes and mortality following renal injury among myocardial infarction patients treated by primary percutaneous intervention.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Comorbidity; Contrast Media; Creatinine; Disease Progr | 2019 |
Low incidence of nephrotoxicity following intravenous administration of iodinated contrast media: a prospective study.
Topics: Acute Kidney Injury; Administration, Intravenous; Aged; Contrast Media; Female; Glomerular Filtratio | 2019 |
Evaluation of iodine contrast-induced acute kidney injury via different injection routes using BOLD-MRI.
Topics: Acute Kidney Injury; Animals; Contrast Media; Disease Models, Animal; Ear Auricle; Femoral Artery; H | 2019 |
Blood Oxygen Level-Dependent Imaging and Intravoxel Incoherent Motion MRI of Early Contrast-Induced Acute Kidney Injury in a Rabbit Model.
Topics: Acute Kidney Injury; Animals; Contrast Media; Diffusion Magnetic Resonance Imaging; Disease Models, | 2019 |
Effect of iodinated contrast media on the oxygen tension in the renal cortico-medullary region of pigs.
Topics: Acute Kidney Injury; Animals; Contrast Media; Hemodynamics; Male; Microcirculation; Swine; Triiodobe | 2019 |
Renal function following fistulography in patients with advanced chronic kidney disease.
Topics: Acute Kidney Injury; Aged; Angiography; Arteriovenous Shunt, Surgical; Contrast Media; Glomerular Fi | 2013 |
Low-dose nitrite alleviates early effects of an X-ray contrast medium on renal hemodynamics and oxygenation in rats.
Topics: Acute Kidney Injury; Animals; Blood Flow Velocity; Contrast Media; Dose-Response Relationship, Drug; | 2014 |
Exposure to low- vs iso-osmolar contrast agents reduces NADPH-dependent reactive oxygen species generation in a cellular model of renal injury.
Topics: Acute Kidney Injury; Apoptosis; Contrast Media; Humans; Iohexol; Iopamidol; Kidney; NADP; NADPH Oxid | 2014 |
Iodinated contrast media cause direct tubular cell damage, leading to oxidative stress, low nitric oxide, and impairment of tubuloglomerular feedback.
Topics: Acute Kidney Injury; Animals; Biological Availability; Cell Death; Contrast Media; Feedback, Physiol | 2014 |
Pre-procedural bioimpedance vectorial analysis of fluid status and prediction of contrast-induced acute kidney injury.
Topics: Acute Kidney Injury; Aged; Cohort Studies; Contrast Media; Coronary Angiography; Coronary Artery Dis | 2014 |
Pre-procedural bioimpedance vectorial analysis of fluid status and prediction of contrast-induced acute kidney injury.
Topics: Acute Kidney Injury; Aged; Cohort Studies; Contrast Media; Coronary Angiography; Coronary Artery Dis | 2014 |
Pre-procedural bioimpedance vectorial analysis of fluid status and prediction of contrast-induced acute kidney injury.
Topics: Acute Kidney Injury; Aged; Cohort Studies; Contrast Media; Coronary Angiography; Coronary Artery Dis | 2014 |
Pre-procedural bioimpedance vectorial analysis of fluid status and prediction of contrast-induced acute kidney injury.
Topics: Acute Kidney Injury; Aged; Cohort Studies; Contrast Media; Coronary Angiography; Coronary Artery Dis | 2014 |
Evaluation of intrarenal oxygenation in iodinated contrast-induced acute kidney injury-susceptible rats by blood oxygen level-dependent magnetic resonance imaging.
Topics: Acute Kidney Injury; Acute-Phase Proteins; Animals; Biomarkers; Contrast Media; Feasibility Studies; | 2014 |
Efficacy of preventive interventions for iodinated contrast-induced acute kidney injury evaluated by intrarenal oxygenation as an early marker.
Topics: Acetylcysteine; Acute Kidney Injury; Acute-Phase Proteins; Animals; Biomarkers; Contrast Media; Dise | 2014 |
Significant perturbation in renal functional magnetic resonance imaging parameters and contrast retention for iodixanol compared with iopromide: an experimental study using blood-oxygen-level-dependent/diffusion-weighted magnetic resonance imaging and com
Topics: Acute Kidney Injury; Analysis of Variance; Animals; Contrast Media; Diffusion Magnetic Resonance Ima | 2014 |
Extended renal outcomes with use of iodixanol versus iohexol after coronary angiography.
Topics: Acute Kidney Injury; Age Distribution; Aged; Cohort Studies; Contrast Media; Coronary Angiography; F | 2014 |
Incidence of acute kidney injury after intravenous administration of iodixanol for computed tomographic angiography.
Topics: Acute Kidney Injury; Administration, Intravenous; Aged; Cohort Studies; Coronary Angiography; Female | 2014 |
Intravenous contrast material exposure is not an independent risk factor for dialysis or mortality.
Topics: Acute Kidney Injury; Aged; Contrast Media; Electronic Health Records; Female; Humans; Injections, In | 2014 |
Diadenosine pentaphosphate modulates glomerular arteriolar tone and glomerular filtration rate.
Topics: Acute Kidney Injury; Animals; Arterioles; Dinucleoside Phosphates; Glomerular Filtration Rate; Kidne | 2015 |
A novel contrast-induced acute kidney injury model based on the 5/6-nephrectomy rat and nephrotoxicological evaluation of iohexol and iodixanol in vivo.
Topics: Acute Kidney Injury; Animals; Contrast Media; Disease Models, Animal; Iohexol; Kidney; Male; Nephrec | 2014 |
The risk of acute kidney injury with transjugular intrahepatic portosystemic shunts.
Topics: Acute Kidney Injury; Administration, Intravenous; Aged; Contrast Media; Creatinine; Female; Humans; | 2015 |
Evaluation of urine fibrinogen level in a murine model of contrast-induced nephropathy.
Topics: Acute Kidney Injury; Animals; Biomarkers; Creatinine; Disease Models, Animal; Early Diagnosis; Fibri | 2016 |
[Contrast-induced acute kidney injury after primary percutaneous coronary interventions: Prevalence, predictive factors, and outcomes].
Topics: Acute Coronary Syndrome; Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Contrast Media; Electr | 2015 |
The incidence and significance of acute kidney injury following emergent contrast administration in patients with STEMI and stroke.
Topics: Acute Kidney Injury; Administration, Intravenous; Aged; Cohort Studies; Contrast Media; Creatinine; | 2016 |
Role of Neutrophil Gelatinase-associated Lipocalin in the Detection of Contrast-induced Nephropathy in Patients Undergoing a Coronary Angiography.
Topics: Acute Coronary Syndrome; Acute Kidney Injury; Aged; Contrast Media; Coronary Angiography; Creatinine | 2016 |
Acute kidney damage induced by low- and iso-osmolar contrast media in rats: Comparison study with physiologic MRI and histologic-gene examination.
Topics: Acute Kidney Injury; Animals; Contrast Media; Dose-Response Relationship, Drug; Magnetic Resonance I | 2017 |
Incidences of acute kidney injury, dialysis, and graft loss following intravenous administration of low-osmolality iodinated contrast in patients with kidney transplants.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Female; Glomerular | 2016 |
Gender Difference in the Risk of Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography or Percutaneous Coronary Intervention.
Topics: Acute Kidney Injury; Aged; Contrast Media; Coronary Angiography; Female; Humans; Incidence; Iohexol; | 2017 |
A Novel Technique to Reduce Contrast Exposure During Subclavian Interventions.
Topics: Acute Kidney Injury; Aged; Angiography, Digital Subtraction; Angioplasty, Balloon; Arterial Occlusiv | 2017 |
Contrast-induced acute kidney injury in renal transplant recipients after cardiac catheterization.
Topics: Acute Kidney Injury; Cardiac Catheterization; Contrast Media; Creatinine; Female; Humans; Incidence; | 2009 |
Comment on meta-analyses of trials comparing contrast media.
Topics: Acute Kidney Injury; Aged; Cardiac Catheterization; Confidence Intervals; Contrast Media; Creatinine | 2009 |
Preprocedural score for risk of contrast-induced nephropathy in elective coronary angiography and intervention.
Topics: Acute Kidney Injury; Aged; Angioplasty, Balloon, Coronary; Contrast Media; Coronary Angiography; Fem | 2010 |
Effect of contrast-induced nephropathy on cardiac outcomes after use of nonionic isosmolar contrast media during coronary procedure.
Topics: Acute Kidney Injury; Aged; Biomarkers; Contrast Media; Coronary Angiography; Creatinine; Female; Hem | 2010 |
The relative renal safety of iodixanol and low-osmolar contrast media in patients undergoing percutaneous coronary intervention. Insights from Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).
Topics: Acute Kidney Injury; Angioplasty, Balloon, Coronary; Contrast Media; Female; Humans; Male; Osmolar C | 2010 |
Contrast medium-induced acute kidney injury: comparison of intravenous and intraarterial administration of iodinated contrast medium.
Topics: Acute Kidney Injury; Aged; Angiography, Digital Subtraction; Arterial Occlusive Diseases; Chi-Square | 2011 |
Impact of contrast-induced acute kidney injury with transient or persistent renal dysfunction on long-term outcomes of patients with acute myocardial infarction undergoing percutaneous coronary intervention.
Topics: Acute Kidney Injury; Adult; Aged; Angioplasty, Balloon, Coronary; Contrast Media; Disease Progressio | 2011 |
The osmolality of nonionic, iodinated contrast agents as an important factor for renal safety.
Topics: Acute Kidney Injury; Animals; Biomarkers; Contrast Media; Iohexol; Kidney; Male; Mannitol; Osmolar C | 2012 |
Effect of renin-angiotensin-aldosterone system blockade therapy on incidence of contrast-induced nephropathy in patients with chronic kidney disease.
Topics: Acute Kidney Injury; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme In | 2012 |
Effect of low-osmolar contrast medium iopromide and iso-osmolar iodixanol on DNA fragmentation in renal tubular cell culture.
Topics: Acute Kidney Injury; Cell Line; Contrast Media; DNA Fragmentation; Humans; Iohexol; Kidney; Osmolar | 2013 |
Protection from contrast-induced nephropathy: is the answer in?
Topics: Acetylcysteine; Acute Kidney Injury; Cardiac Catheterization; Contrast Media; Free Radical Scavenger | 2003 |
Contrast nephropathy post cardiac resynchronization therapy: an under-recognized complication with important morbidity.
Topics: Acute Kidney Injury; Aged; Cardiac Pacing, Artificial; Contrast Media; Creatinine; Defibrillators, I | 2005 |
Contrast dose-to-creatinine clearance ratio as a potential indicator of risk for radiocontrast-induced nephropathy: correlation of D/CrCL with area under the contrast concentration-time curve using iodixanol.
Topics: Acute Kidney Injury; Area Under Curve; Chromatography, High Pressure Liquid; Contrast Media; Creatin | 2005 |
Nephrotoxicity of low-osmolality versus iso-osmolality contrast agents: impact of N-acetylcysteine.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Contrast Media; Female; Fluid Therapy; Humans; Iohexol; K | 2005 |
Contrast-induced nephropathy in urgent coronary interventions.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Analysis of Variance; Angioplasty, Balloon, Coronary; | 2006 |
Visipaque (iodixanol) and hexabrix (ioxaglate) in renal insufficiency.
Topics: Acute Kidney Injury; Contrast Media; Coronary Angiography; Coronary Disease; Humans; Incidence; Ioxa | 2007 |
Evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in coronary angiography.
Topics: Acute Kidney Injury; Contrast Media; Coronary Angiography; Coronary Disease; Humans; Ioxaglic Acid; | 2007 |
Acute renal haemodynamic effects of radiocontrast media in patients undergoing left ventricular and coronary angiography.
Topics: Acute Kidney Injury; Aged; Blood Flow Velocity; Contrast Media; Coronary Angiography; Creatinine; Fe | 2008 |
Influence of the timing of cardiac catheterization and the amount of contrast media on acute renal failure after cardiac surgery.
Topics: Acute Kidney Injury; Age Factors; Aged; Cardiac Catheterization; Cardiac Surgical Procedures; Cardio | 2008 |
Renal effects of iodixanol in healthy volunteers and patients with severe renal failure.
Topics: Acute Kidney Injury; Contrast Media; Glomerular Filtration Rate; Humans; Kidney; Kidney Failure, Chr | 1995 |